Observational studyOphthalmology. Retina2020

Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study.

Georgios Bontzos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.